4-HO-MPMI
Summary 4-HO-MPMI, alternatively referred to as 4-Hydroxy-N-methyl-(α, N-trimethylene)-tryptamine or lucigenol, belongs to the category of tryptamine derivatives and possesses psychedelic properties. Originating in the late 1990s, it was developed under the leadership of David Nichols at Purdue University. This compound exhibits hallucinogenic effects in animal trials, displaying potency akin to the amphetamine-derived psychedelic DOI. Notably, …